Dogwood Therapeutics DWTX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's retained earnings?
- Dogwood Therapeutics (DWTX) reported retained earnings of -$113.06M in Q1 2026.
- How has Dogwood Therapeutics's retained earnings changed year-over-year?
- Dogwood Therapeutics's retained earnings decreased by 33.4% year-over-year, from -$84.74M to -$113.06M.
- What is the long-term trend for Dogwood Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Dogwood Therapeutics's retained earnings has grown at a 31.0% compound annual growth rate (CAGR), from -$27.97M to -$108.08M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.